<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab2">
 <label>Table 2</label>
 <caption>
  <p>Treatment-emergent adverse events occurring in NPC patients during the study in the safety analysis set</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left" rowspan="2">Adverse event</th>
    <th align="left" colspan="5">Famitinib alone</th>
    <th align="left" colspan="5">Famitinib with CCRT</th>
   </tr>
   <tr>
    <th align="left">Grade 1–2</th>
    <th align="left">Grade 3</th>
    <th align="left">Grade 4</th>
    <th align="left">Grade 5</th>
    <th align="left">Total</th>
    <th align="left">Grade 1–2</th>
    <th align="left">Grade 3</th>
    <th align="left">Grade 4</th>
    <th align="left">Grade 5</th>
    <th align="left">Total</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left">Leukopenia</td>
    <td align="left">1 (5%)</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td char="." align="char">0</td>
    <td align="left">1 (5%)</td>
    <td align="left">2 (10%)</td>
    <td align="left">17 (85%)</td>
    <td align="left">1 (5%)</td>
    <td char="." align="char">0</td>
    <td align="left">20 (100%)</td>
   </tr>
   <tr>
    <td align="left">Neutropenia</td>
    <td align="left">1 (5%)</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td char="." align="char">0</td>
    <td align="left">1 (5%)</td>
    <td align="left">9 (45%)</td>
    <td align="left">10 (50%)</td>
    <td align="left">1 (5%)</td>
    <td char="." align="char">0</td>
    <td align="left">20 (100%)</td>
   </tr>
   <tr>
    <td align="left">Anaemia</td>
    <td align="left">2 (10%)</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td char="." align="char">0</td>
    <td align="left">2 (10%)</td>
    <td align="left">16 (80%)</td>
    <td align="left">4 (20%)</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td align="left">20 (100%)</td>
   </tr>
   <tr>
    <td align="left">Radiation mucositis</td>
    <td align="left">0</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td char="." align="char">0</td>
    <td align="left">0</td>
    <td align="left">16 (80%)</td>
    <td align="left">3 (15%)</td>
    <td align="left">1 (5%)</td>
    <td char="." align="char">0</td>
    <td align="left">20 (100%)</td>
   </tr>
   <tr>
    <td align="left">Nausea and vomiting</td>
    <td align="left">0</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td char="." align="char">0</td>
    <td align="left">0</td>
    <td align="left">16 (80%)</td>
    <td align="left">1 (5%)</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td align="left">17 (85%)</td>
   </tr>
   <tr>
    <td align="left">Radiation dermatitis</td>
    <td align="left">0</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td char="." align="char">0</td>
    <td align="left">0</td>
    <td align="left">13 (65%)</td>
    <td align="left">0</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td align="left">13 (65%)</td>
   </tr>
   <tr>
    <td align="left">Weight loss</td>
    <td align="left">0</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td char="." align="char">0</td>
    <td align="left">0</td>
    <td align="left">15 (75%)</td>
    <td align="left">0</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td align="left">15 (75%)</td>
   </tr>
   <tr>
    <td align="left">Proteinuria</td>
    <td align="left">1 (5%)</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td char="." align="char">0</td>
    <td align="left">1 (5%)</td>
    <td align="left">15 (75%)</td>
    <td align="left">1 (5%)</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td align="left">16 (80%)</td>
   </tr>
   <tr>
    <td align="left">Thrombopenia</td>
    <td align="left">0</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td char="." align="char">0</td>
    <td align="left">0</td>
    <td align="left">10 (50%)</td>
    <td align="left">3 (15%)</td>
    <td align="left">1 (5%)</td>
    <td char="." align="char">0</td>
    <td align="left">14 (70%)</td>
   </tr>
   <tr>
    <td align="left">Hypertension</td>
    <td align="left">3 (15%)</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td char="." align="char">0</td>
    <td align="left">3 (15%)</td>
    <td align="left">8 (40%)</td>
    <td align="left">1 (5%)</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td align="left">9 (45%)</td>
   </tr>
   <tr>
    <td align="left">Liver function impairment</td>
    <td align="left">3 (15%)</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td char="." align="char">0</td>
    <td align="left">3 (15%)</td>
    <td align="left">10 (50%)</td>
    <td align="left">1 (5%)</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td align="left">11 (55%)</td>
   </tr>
   <tr>
    <td align="left">Hypertriglyceridemia</td>
    <td align="left">5 (25%)</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td char="." align="char">0</td>
    <td align="left">5 (25%)</td>
    <td align="left">5 (25%)</td>
    <td align="left">0</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td align="left">5 (25%)</td>
   </tr>
   <tr>
    <td align="left">Hearing impairment</td>
    <td align="left">0</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td char="." align="char">0</td>
    <td align="left">0</td>
    <td align="left">4 (20%)</td>
    <td align="left">0</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td align="left">4 (20%)</td>
   </tr>
   <tr>
    <td align="left">Renal impairment</td>
    <td align="left">0</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td char="." align="char">0</td>
    <td align="left">0</td>
    <td align="left">4 (20%)</td>
    <td align="left">0</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td align="left">4 (20%)</td>
   </tr>
   <tr>
    <td align="left">Hematuria</td>
    <td align="left">2 (10%)</td>
    <td align="left">1 (5%)</td>
    <td char="." align="char">0</td>
    <td char="." align="char">0</td>
    <td align="left">3 (15%)</td>
    <td align="left">4 (20%)</td>
    <td align="left">1 (5%)</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td align="left">5 (25%)</td>
   </tr>
   <tr>
    <td align="left">Haemorrhage</td>
    <td align="left">0</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td char="." align="char">0</td>
    <td align="left">0</td>
    <td align="left">2 (10%)</td>
    <td align="left">0</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td align="left">2 (10%)</td>
   </tr>
   <tr>
    <td align="left">Skin rash</td>
    <td align="left">2 (10%)</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td char="." align="char">0</td>
    <td align="left">2 (10%)</td>
    <td align="left">1 (5%)</td>
    <td align="left">0</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td align="left">1 (5%)</td>
   </tr>
   <tr>
    <td align="left">Hypothyroidism</td>
    <td align="left">0</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td char="." align="char">0</td>
    <td align="left">0</td>
    <td align="left">0</td>
    <td align="left">0</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td align="left">0</td>
   </tr>
   <tr>
    <td align="left">Hypercholesterolemia</td>
    <td align="left">1 (5%)</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td char="." align="char">0</td>
    <td align="left">1 (5%)</td>
    <td align="left">0</td>
    <td align="left">0</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td align="left">0</td>
   </tr>
   <tr>
    <td align="left">Elevated total bilirubin</td>
    <td align="left">1 (5%)</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td char="." align="char">0</td>
    <td align="left">1 (5%)</td>
    <td align="left">1 (5%)</td>
    <td align="left">0</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td align="left">1 (5%)</td>
   </tr>
   <tr>
    <td align="left">Elevated GGT</td>
    <td align="left">2 (10%)</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td char="." align="char">0</td>
    <td align="left">2 (10%)</td>
    <td align="left">2 (10%)</td>
    <td align="left">0</td>
    <td align="left">0</td>
    <td char="." align="char">0</td>
    <td align="left">2 (10%)</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <italic>CCRT</italic> concurrent chemoradiotherapy, 
   <italic>GGT</italic> gamma glutamyl transpeptidase, 
   <italic>NPC</italic> nasopharyngeal carcinoma
  </p>
 </table-wrap-foot>
</table-wrap>
